Fundz

Coriell Life Sciences, Inc. reported raising $9.47 Million in an initial SEC Form D filing, from an offering of $10 Million

PRIVATEMay 06, 2019$9.5M of $10M raised

Amount Raised

$9.47 Million

$9.47 Million sold, per SEC Form D (first sale May 6, 2019)

Round Type

Venture

PhiladelphiaBiotechnology

Quick answer

Coriell Life Sciences, Inc. raised $9.47 Million in a funding round, dated May 6, 2019. Coriell Life Sciences, Inc. is based in Philadelphia, Pennsylvania, United States.

How much did Coriell Life Sciences, Inc. raise?
Coriell Life Sciences, Inc. raised $9.47 Million in a funding round on May 6, 2019.
What does Coriell Life Sciences, Inc. do?
Coriell Life Sciences provides a DNA-based medication management program that leverages the power of pharmacogenomics (PGx) to provide innovative and cost-effective precision medicine.
Where is Coriell Life Sciences, Inc. based and how big is it?
Coriell Life Sciences, Inc. is based in Philadelphia, Pennsylvania, United States.

Source: Fundz verified event record.

Who else raised in Biotechnology around the same time

Companies in the same sectors as Coriell Life Sciences, Inc. that raised within 45 days of this round, from Fundz verified event records.

  • Akston raised $2.5M (Seed) on June 20, 2019.
  • Breethe raised $6M on June 20, 2019.
  • Codexis raised $50M on June 20, 2019.
  • StemBioSys Inc. raised $1.4M (Seed) on June 19, 2019.
  • AKONNI BIOSYSTEMS INC raised $1.8M (Seed) on June 19, 2019.
  • Vanquish Oncology, Inc. raised $1M (Seed) on June 19, 2019.

Who to call at Coriell Life Sciences, Inc., and when

A new round usually means Coriell Life Sciences, Inc. is about to hire and buy. The teams that reach out first get the meeting.

  • An alert the day Coriell Life Sciences, Inc. raises, hires an executive or expands, scored against what you sell
  • The decision-makers there, with verified emails
  • Who you already know at Coriell Life Sciences, Inc., from your own LinkedIn network

Works inside ChatGPT and Claude. Ask who to call at Coriell Life Sciences, Inc.. With Fundz connected, it knows.

Watch Fundz in
See plan options
Trusted byOracleSnowflakeCloudflareLinkedInGoogleSalesforce 4.8/5 on G2

Company Information

Company

Coriell Life Sciences, Inc.

Location

4747 SOUTH BROAD STREET

Philadelphia, Pennsylvania, United States

About

Coriell Life Sciences provides a DNA-based medication management program that leverages the power of pharmacogenomics (PGx) to provide innovative and cost-effective precision medicine. The program is perfect for self-insured businesses, government benefit providers, capitated providers, ACOs, and single-payer systems.

AI made execution free. Knowing first is the whole game now.

Fundz sees it the moment Coriell Life Sciences, Inc. raises, hires an exec or expands, usually minutes after it happens, and tells you who to reach.

Predictive Intelligence
Strategic

ML-powered predictions for Coriell Life Sciences, Inc.'s next move

See what Strategic adds

Coriell Life Sciences, Inc. raised. Fundz records a round at a median of 3.6 minutes from the SEC filing, with the decision-maker attached.

145 of these a day, filtered to the companies you pick, with the decision-maker attached.

5 screens from a live account. No signup.

Fundz is a real-time business intelligence platform powered by agentic AI that proactively delivers personalized daily signals, including funding rounds, executive changes, M&A activity, 13F institutional filings, SEC 8-K events, investor activity, and website modifications, based on each user's watchlist and ICP. A trusted data source at firms such as BlackRock, Oracle, Kleiner Perkins, LinkedIn, HubSpot, and Cloudflare, Fundz democratizes the institutional-grade intelligence that previously required a PitchBook or Bloomberg terminal. Features include Daily Briefing for AI-powered daily briefings, and unified cross-signal alerts across 281,000+ organizations. Developers and data teams can access these signals programmatically via the Fundz Funding Data API, with transparent published pricing.